P04156 (PRIO_HUMAN) Homo sapiens (Human)

Major prion protein UniProtKBInterProSTRINGInteractive Modelling

253 aa; Sequence (Fasta) ; 1 identical sequence: Homo sapiens: Q53YK7

Available Structures

69 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
Probing the N-terminal beta-sheet conversion in the crystal structure of the full-length human prio… Heteromer
117-225
Assess
Probing the N-terminal beta-sheet conversion in the crystal structure of the human prion protein bo… Heteromer
118-224
Assess
Human prion protein (PrP) fragment 119-231 (G127V M129 variant) complexed to ICSM 18 (anti-Prp ther… Heteromer
125-225
SO4;
Assess
Human prion protein (PrP) fragment 119-231 (G127V V129 variant) complexed to ICSM 18 (anti-Prp ther… Heteromer
125-223
SO4;
Assess
Structure of ICSM 18 (anti-Prp therapeutic antibody) Fab fragment complexed with human Prp fragment… Heteromer
125-223
SO4;
Assess
Structure of POM1 FAB fragment complexed with human PrPc Fragment 120-230 Heteromer
126-222
NA;
Assess
Fragment of human prion protein Heteromer
177-216
FE;CIT;
Assess
Fragment of human prion protein Heteromer
177-216
Assess
Cryo-EM structure of human PrP23-144 amyloid fibrilshomo-20-mer108-141
Assess
GYMLGS segment 127-132 from human prion with M129homo-12-mer127-132
Assess
GYVLGS segment 127-132 from human prion with V129homo-12-mer127-132
12×ACY;
Assess
Structure of Type I Prion filaments from Gerstmann-Straussler-Scheinker diseasehomo-10-mer80-141
Assess
Structure of Type II Prion filaments from Gerstmann-Straussler-Scheinker diseasehomo-10-mer80-141
Assess
Cryo-EM structure of amyloid fibril formed by full-length human prion proteinhomo-10-mer170-229
Assess
Human prion protein fibril, M129 varianthomo-10-mer106-145
Assess
IIHFGS segment 138-143 from human prionhomo-10-mer138-143
10×MPD;
Assess
GAVVGG segment 119-124 from human prionhomo-8-mer119-124
Assess
AGAAAA segment 113-118 from human prionhomo-8-mer113-118
MLI;
Assess
Cryo-EM structure of amyloid fibril formed by familial prion disease-related mutation E196Khomo-6-mer175-217
Assess
Crystal structure of the human prion protein reveals a mechanism for oligomerizationhomo-2-mer119-226
CD;CL;
Assess
Human prion protein variant V129 domain swapped dimerhomo-2-mer120-225
CD;CL;
Assess
Human prion protein variant D178N with M129homo-2-mer126-228
CD;
Assess
Human prion protein variant F198S with V129homo-2-mer125-227
CD;
Assess
Human prion protein variant V129 domain swapped dimerhomo-2-mer125-227
Assess
Human prion protein variant F198S with M129homo-2-mer125-226
CD;
Assess
Human prion protein variant D178N with V129homo-2-mer126-223
CD;CL;
Assess
Human prion protein with E219K protective polymorphismmonomer90-231
Assess
human prion protein mutant HuPrP(90-231, M129, V210I)monomer90-231
Assess
Three dimensional structure of HuPrP(90-231 M129 Q212P)monomer90-231
Assess
Solution-state NMR structure of the human prion proteinmonomer90-231
Assess
Solution-state NMR structure of prion protein mutant V210I at neutral pHmonomer90-231
Assess
structure for wildtype Human prion protein (M129)monomer91-231
Assess
Solution structure of the pathogenic mutant G131V of Human prion protein (91-231)monomer91-231
Assess
structure for the protective mutant G127V of Human prion proteinmonomer91-231
Assess
PrP226* - Solution-state NMR structure of truncated human prion proteinmonomer90-226
Assess
HUMAN PRION PROTEIN 121-230 M166C/E221Cmonomer119-230
Assess
Solution NMR structure of the V209M variant of the human prion protein (residues 90-231)monomer120-231
Assess
HUMAN PRION PROTEIN MUTANT E200K FRAGMENT 90-231monomer125-231
Assess
NMR Studies of a Pathogenic Mutant (D178N) of the Human Prion Proteinmonomer125-231
Assess
HUMAN PRION PROTEIN (MUTANT E200K) FRAGMENT 90-231monomer125-231
Assess
Human prion protein fragment 90-230monomer125-228
Assess
Human prion protein variant R220Kmonomer125-228
Assess
HUMAN PRION PROTEIN AT PH 7.0monomer125-228
Assess
Human prion protein variant R220Kmonomer125-228
Assess
Human prion protein variant S170Nmonomer125-228
Assess
HUMAN PRION PROTEIN AT PH 7.0monomer125-228
Assess
Human prion protein variant S170Nmonomer125-228
Assess
Human prion protein fragment 121-230monomer125-228
Assess
Human prion protein variant M166Vmonomer125-228
Assess
Human prion protein fragment 90-230monomer125-228
Assess
Human prion protein fragment 121-230monomer125-228
Assess
Human prion proteinmonomer125-228
Assess
Human prion proteinmonomer125-228
Assess
Human prion protein variant M166Vmonomer125-228
Assess
Human prion protein variant V129monomer125-227
Assess
Crystal Structure of Human Prion Protein 90-231monomer127-224
CD;CL;
Assess
Structure of the CHR of the Prion protein in DPC Micellesmonomer110-136
Assess
Human prion protein 61-84monomer61-84
Assess
hPrP-173-195 solution structuremonomer173-195
Assess
hPrP-173-195-D178N solution structuremonomer173-195
Assess
hPrP180-195 structuremonomer180-195
Assess
Segment from the S170N mutant of the human prion protein 168-176 EYNNQNNFVmonomer168-176
Assess
Segment from the Y169F mutant of the human prion protein 168-176 EFSNQNNFVmonomer168-176
Assess
Segment from the human prion protein 168-176 EYSNQNNFVmonomer168-176
Assess
Human prion protein 61-68monomer77-84
Assess
Segment from the human prion protein 169-175 YSNQNNFmonomer169-175
Assess
Segment from Y169G mutant of the human prion protein 169-175 GSNQNNFmonomer169-175
ACT;ZN;
Assess
Prion peptidemonomer127-132
Assess
Prion peptidemonomer127-132
Assess

1 SWISS-MODEL model

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
6fnv.1.Amonomer0.5893-229
91.97
Assess